A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI.
David Adlam, Maciej Zarebinski, Neal G Uren, Pawel Ptaszynski, Keith G Oldroyd, Shahzad Munir, Azfar Zaman, Hussain Contractor, Róbert Gábor Kiss, István Édes, Joanna Szachniewicz, Gergely Gyorgy Nagy, Mario J Garcia, János Tomcsanyi, John Irving, Andrew S P Sharp, Piotr Musialek, Géza Lupkovics, Cheerag Shirodaria, Joseph B Selvanayagam, Pauline Quinn, Leong Ng, Mark Roth, Michael A Insko, Ben Haber, Stephen Hill, Lori Siegel, Simon Tulloch, Keith M Channon
International journal of cardiology 2022;347():1-7